Medistim ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	209.79	212.09	179.21	153.87	152.64	129.49
Cash & Short-Term Investments	209.79	212.09	179.21	153.87	152.64	129.49
Cash Growth	14.36%	18.35%	16.47%	0.81%	17.88%	80.12%
Accounts Receivable	104.47	86.39	68.98	74.3	101.66	68.63
Other Receivables	17.45	18.11	20.42	18	17.26	10.96
Total Trade Receivables	121.91	104.5	89.4	92.3	118.92	79.59
Inventory	160.39	161.13	160.52	145.39	114.33	97.41
Total Current Assets	492.08	477.72	429.13	391.57	385.89	306.5
Net Property, Plant & Equipment	88.1	79.39	71.78	57.31	51.31	58.86
Other Intangible Assets	101.7	86.1	60.72	45.38	36.07	30.17
Other Long-Term Assets	-	17.4	13.34	11.47	9.38	7.72
Total Assets	681.89	660.6	574.97	505.72	482.66	403.24
Accounts Payable	-	26.63	17.73	25.08	24.47	13.21
Current Portion of Leases	-	11.59	9.31	8.38	7.09	7.11
Other Current Liabilities	-	104.99	80.33	60.82	68.27	57.29
Total Current Liabilities	129.64	143.21	107.37	94.28	99.82	77.6
Long-Term Leases	34.6	37.68	25.06	9.26	10.02	17.08
Other Long-Term Liabilities	10.9	11.31	5.93	4.23	5.13	2.51
Total Long-Term Liabilities	45.5	48.99	30.99	13.49	15.15	19.59
Total Liabilities	175.14	192.19	138.36	107.78	114.97	97.19
Common Stock	4.59	4.59	4.59	4.59	4.59	4.59
Treasury Stock	-	-0.01	-0.01	-0.01	-0.02	-0.03
Additional Paid-in Capital	44.17	72.74	67.66	66.6	60.59	55.2
Accumulated Other Comprehensive Income	-	22.28	35.58	19.39	16.8	6.14
Retained Earnings	457.99	368.82	328.8	307.38	285.74	240.16
Total Common Shareholders' Equity	506.74	468.41	436.61	397.94	367.69	306.05
Shareholders' Equity	506.74	468.41	436.61	397.94	367.69	306.05
Total Liabilities & Equity	681.89	660.6	574.97	505.72	482.66	403.24
Total Debt	34.6	49.27	34.36	17.64	17.11	24.19
Net Cash (Debt)	175.19	162.82	144.85	136.23	135.54	105.3
Net Cash Growth	7.60%	12.41%	6.33%	0.51%	28.72%	221.24%
Net Cash Per Share	9.59	8.91	7.91	7.45	7.42	5.77
Book Value	506.74	468.41	436.61	397.94	367.69	306.05
Book Value Per Share	27.73	25.63	23.84	21.75	20.12	16.77
Tangible Book Value	405.04	382.31	375.89	352.57	331.62	275.88
Tangible Book Value Per Share	22.17	20.92	20.52	19.27	18.14	15.12